Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SightStream Biotherapeutics logo — Developing unique regenerative & restorative therapies for u...

SightStream Biotherapeutics

Developing unique regenerative & restorative therapies for unmet needs in the ophthalmic space

Founded 2022 United States United States 6 employees Biotechnology, Health Care +1

General Information

Company Name SightStream Biotherapeutics
Founded Year 2022
Location United States United States
Employees 6
Industries Biotechnology, Health Care, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with SightStream Biotherapeutics. To contact SightStream Biotherapeutics, visit sightstreambio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SightStream Biotherapeutics

SightStream Biotherapeutics is a biotechnology startup founded in 2020, with its headquarters in the United States. The company's focus is on developing unique regenerative & restorative therapies for unmet needs in the ophthalmic space. This disruptive approach aims to address critical gaps in ophthalmic care, presenting a promising opportunity for innovation in the health care industry. SightStream Biotherapeutics' commitment to advancing the field of ophthalmology through groundbreaking therapies positions it as a compelling prospective investment. Given the potential to address unmet needs in the ophthalmic space with regenerative and restorative solutions, the startup presents an exciting opportunity for venture capital firms aiming to support innovation in biotechnology and healthcare. The lack of specific information regarding the company's last investment and last investment investors could be a point of interest for potential investors, as it may suggest an openness to new partnerships or strategic funding. As a result, monitoring SightStream Biotherapeutics for upcoming investment rounds could prove beneficial for venture capital entities seeking to engage with pioneering ventures in the biotechnology and healthcare sectors.

Taxonomy: Ophthalmic therapies, Regenerative medicine, Cell death reversal, Cytoprotectives, Pro-regenerative technologies, Ocular health, Healthcare innovation, Medfield, Massachusetts, Ocular cell damage, Unmet medical needs, Ophthalmology, Biomedical technology, Cell therapy

No funding data available for SightStream Biotherapeutics yet.

SightStream Biotherapeutics Alternatives & Competitors

SightStream Biotherapeutics vs
DiscGenics
DiscGenics United States

REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN

Series C
40 employees
Biotechnology, Health Care
SightStream Biotherapeutics vs
Khloris Biosciences
Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular...

Venture round
Biotechnology, Life Sciences
SightStream Biotherapeutics vs
Berlin Institute of Health in der Charité
Berlin Institute of Health in der Charité Germany

Aus Forschung wird Gesundheit

561 employees
Biotechnology, Health Care

FAQ About SightStream Biotherapeutics

Developing unique regenerative & restorative therapies for unmet needs in the ophthalmic space
SightStream Biotherapeutics was founded in 2022.
SightStream Biotherapeutics is headquartered in United States.
SightStream Biotherapeutics operates in Biotechnology, Health Care and Life Sciences. Its work centres on Ophthalmic therapies, Regenerative medicine, Cell death reversal and Cytoprotectives.
SightStream Biotherapeutics has approximately 6 employees.
Top alternatives and competitors to SightStream Biotherapeutics include DiscGenics, Khloris Biosciences, Berlin Institute of Health in der Charité, Vedere Bio II, Amplicore Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SightStream Biotherapeutics and DiscGenics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SightStream Biotherapeutics, https://bouncewatch.com/company/sightstream-biotherapeutics, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes